Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 79630 - National Center for Advancing Translational Sciences Advisory Council - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Center for Advancing Translational Sciences Advisory CouncilAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number79630
Original Establishment Date2/6/2012Committee StatusChartered
Actual Termination Date Committee URLhttp://www.ncats.nih.gov/advisory/council
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*23
Current Charter Date2/7/2020Designated Fed Officer Position Title*Director, Office of Grants Management and Scientific Review
Date Of Renewal Charter2/7/2022Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Anna
Exempt From Renewal*NoDesignated Federal Officer Middle NameL.
Specific Termination AuthorityDesignated Federal Officer Last Name*Ramsey-Ewing
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPHD
Specific Establishment Authority*42 USC 217aDesignated Federal Officer Phone*(301) 435-0809
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*
Exempt From EO 13875 Discretionary CmteExempt: Merit Review PanelDesignated Federal Officer Email*anna.ramseyewing@nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Other Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Section 492 of the PHS Act states that The Secretary...shall by regulation require appropriate technical and scientific peer review of -- (A) applications...; and (B)...biomedical and behavioral research and development contracts.... This council is composed of both scientific and public members who provide the second level of peer review; advise on policy development, program implementation and evaluation; and identify research needs and opportunities of the Institute. Of the applications that were reviewed by initial review groups for the National Center for Advancing Translational Sciences, the Council reviewed 1304 applications in the amount of $2,421,246,454.
How is membership balanced?*The Council will consist of no more than 18 members appointed by the Secretary (appointed members) and the following nonvoting ex officio members: the Secretary; the Director, NIH; the Director, NCATS; and any additional officers or employees of the Department of Health and Human Services as the Secretary determines necessary 4 for the Council to effectively carry out its functions. Appointed members must be eligible to serve as Special Government Employees (SGEs) and will serve as SGEs. Of the appointed members, two-thirds will be selected from among the leading representatives of the health and scientific disciplines (including not less than 2 individuals who are leaders in the fields of public health and the behavioral or social sciences) relevant to the activities of the NCATS, particularly representatives of the health and scientific disciplines in the areas of drug development and translational sciences. One-third of the members will be appointed by the Secretary from the general public and will include leaders in the fields of public policy, law, health policy, economics, and management.
How frequent & relevant are cmte mtgs?*The council met three times during this reporting period. Meetings are scheduled to be held not less than three times each fiscal year. The National Center for Advancing Translational Sciences Advisory Council provides advice on a continuing basis on the type of scientific research programs that should be supported and on how to carry out the designated mission and responsibilities of the Institute. It also provides ongoing review of the relevance and effectiveness of the existing programs.
Why advice can't be obtained elsewhere?*The National Center for Advancing Translational Sciences Advisory Council is composed of both scientific and public members who provide the second level of review for research grant applications; advise on policy development, program implementation and evaluation; and identify research needs and opportunities of the Center. The quality, scope, and balance of advice from this council cannot be obtained from NIH staff or from other established sources because the membership of the council is constituted to meet the specific requirements of the mandated mission of the council and of the Center.
Why close or partially close meetings?The meetings of the National Center for Advancing Translational Sciences Advisory Council was closed to the public for the review of grant applications. Sections 552b(c)(4) and 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal confidential trade secrets or commercial property such as patentable material and personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksCommittee Function: Other - National Scientific and Advisory.

Reports: This committee did not produce any public reports during the fiscal year.

The DFO and Decision Maker are the same person, the Director, Office of Grants Management and Scientific Review, based on the assignment of duties within the Center.

The appointments of members Barket, Morgus, Marks, and Sherer were extended to 2/27/21. Montgomery-Rice resigned 01/01/2020 and Merchant resigned 02/28/20, both resigned prior to their term ending.

Daily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employee due to membership on this committee.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsYes
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentAn action of “approved” or “recommended” for grants receiving review by this Council [or Board] does not infer that the grant will be or has been funded. Research grant applications submitted to NIH must go through a two-step review process that includes the initial peer review for scientific and technical merit and a second step of review and approval by a National Advisory Council that includes program relevance. In addition, prior to an award or funding being made, NIH staff must conduct an administrative review for a number of other considerations. These include alignment with NIH’s funding principles, review of the project budget, assessment of the applicant’s management systems, determination of applicant eligibility, and compliance with public policy requirements. After all these steps have been completed, NIH officials make funding decisions on individual grant applications.
Outcome Implement Laws/Reg RequirementsNoGrants Review*Yes
Outcome OtherNoNumber Of Grants Reviewed1,304
Outcome CommentN/ANumber Of Grants Recommended1,304
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$2,421,246,454.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new way to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*8,196Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe number of recommendations includes the second level review of grant applications.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*Written and oral reports.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information. Section 492 of the Public Health Service Act states that “The Secretary....shall by regulation require appropriate technical and scientific peer review of –(A) applications ...; and (B) ...biomedical and behavioral research and development contracts...”The National Center for Advancing Translational Sciences Advisory Council provides second level peer review, makes recommendations for support of grants, contracts proposals, and cooperative agreements; advises on policy development, program implementation and evaluation; and identifies research needs of the National Center for Advancing Translational Sciences.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$4,000.00Est Payments to Non-Fed Members Next FY*$4,000.00
Payments to Federal Members*$4,585.00Est. Payments to Fed Members Next FY*$4,585.00
Payments to Federal Staff*$239,100.00Estimated Payments to Federal Staff*$245,317.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$15,300.00Est. Other Costs Next FY*$15,607.00
Total Costs$262,985.00Est. Total Next FY*$269,509.00
Federal Staff Support (FTE)*1.70Est. Fed Staff Support Next FY*1.70
Cost RemarksDue to the COVID-19 pandemic, FY20 meetings held after March 12, 2020 were virtual only, which reduced committee operational costs.Est Cost RemarksProjected costs are based on meetings held virtually. If face to face meetings resume, committee costs for FY21 may be higher.
Hide Section - Interest Areas

Interest Areas

Category
Area
Basic Science
Basic Sciences
Health
Health Care
Medicine
Diseases
Illnesses
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036615National Center for Advancing Translational Sciences Advisory Council2019
 COM-034828National Center for Advancing Translational Sciences Advisory Council2018
 COM-002022National Center for Advancing Translational Sciences Advisory Council2017
 COM-002376National Center for Advancing Translational Sciences Advisory Council2016
 COM-004085National Center for Advancing Translational Sciences Advisory Council2015
 COM-004393National Center for Advancing Translational Sciences Advisory Council2014
 COM-005896National Center for Advancing Translational Sciences Advisory Council2013
 COM-006623National Center for Advancing Translational Sciences Advisory Council2012